One of the strongest performing NBFC's + Pharma companies where both businesses are growing. Many doubted the DHFL acquisition but DHFL always was a solid company and now they have it without having much interest dues to make. The company reported a Q1 profit of 300+ cr which will supplement their income.
Long above 2790 and again above 2860 for targets of 3200. After first purchase SL can be around 2675.